Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 1:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 3
1 (50.0%)Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
- First Posted Date
- 2022-02-03
- Last Posted Date
- 2022-03-17
- Lead Sponsor
- Biomad AS
- Target Recruit Count
- 3000
- Registration Number
- NCT05222425
- Locations
- 🇮🇶
Directorate of health of Sulaimani, Iraq -KRG, Sulaymaniyah, Iraq
Treatment of Covid-19 With a Herbal Compound, Xagrotin
Phase 1
Completed
- Conditions
- Covid19
- First Posted Date
- 2021-08-24
- Last Posted Date
- 2021-12-02
- Lead Sponsor
- Biomad AS
- Target Recruit Count
- 661
- Registration Number
- NCT05017493
- Locations
- 🇮🇶
Directorate of health of Sulaimani, Iraq -KRG, Sulaymaniyah, Iraq
News
No news found